DoH adds Al Ain stroke CoE at STMC, creating 3-site Abu Dhabi network

Department of Health – Abu Dhabi (DoH) designated SEHA Sheikh Tahnoon Bin Mohammed Medical City (STMC) in Al Ain as a Centre of Excellence for stroke on 9 October 2026, adding a third specialist stroke site to Abu Dhabi’s network.

For Dubai clinics regulated by the Dubai Health Authority (DHA), the immediate issue is referral discipline for patients whose family, employer or insurer coverage links them to Abu Dhabi. For Abu Dhabi and Al Ain operators regulated by DoH, the designation changes the map for acute stroke transfer and post-acute rehabilitation planning. For Northern Emirates providers regulated by the Ministry of Health and Prevention (MOHAP), it adds another UAE referral option for complex cases that need endovascular or neurosurgical input.

What DoH approved

STMC is part of PureHealth and a subsidiary of SEHA. DoH said the hospital will provide comprehensive stroke treatment, including vascular surgeries, neurosurgical interventions, advanced clot-dissolving therapies, acute stroke care and integrated rehabilitation. The announcement is available from DoH Abu Dhabi.

The designation strengthens our growing network of stroke CoEs, with two already established in Abu Dhabi and now a third in Al Ain, thereby significantly expanding access to specialised stroke care throughout the community. — H.E. Dr. Noura Al Ghaithi, Undersecretary, Department of Health – Abu Dhabi

The two earlier DoH stroke CoEs are Cleveland Clinic Abu Dhabi and Sheikh Shakhbout Medical City. DoH’s public Centre of Excellence page listed those two stroke sites before this STMC update, alongside CoE categories such as adult cardiac surgery, paediatric cardiac surgery, bariatric surgery and haematopoietic stem cell transplantation.

STMC has American Heart Association (AHA) accreditation as a Comprehensive Stroke Centre, according to DoH. DoH also said STMC uses AI-enhanced CT perfusion, CT angiography, MRI stroke protocols and tele-stroke services for remote expert consultations.

What clinics and insurers should implement

The practical effect is operational. Emergency departments, urgent care centres and outpatient cardiology or neurology clinics need a written stroke escalation pathway that separates early stabilisation from transfer to a CoE. A 13 June 2024 DoH circular on stroke CoEs said primary stroke centres should continue intravenous tissue plasminogen activator treatment and transfer patients to the nearest CoE if surgery is required. Stroke-ready centres should provide IV-tPA in the emergency department only, then transfer the patient to the nearest CoE after stabilisation.

• COOs should confirm ambulance transfer instructions, escalation contacts and documentation handover for suspected large-vessel occlusion cases.
• CFOs should check DoH Shafafiya prices, payer contracts and pre-authorisation rules before quoting patient liability for thrombectomy, neurosurgery or rehabilitation.
• Medical directors should audit whether emergency and outpatient teams use a time-of-onset field in every suspected stroke referral.
• CIOs should test whether CT, CTA, MRI and discharge summaries can be shared across facility and payer workflows without manual re-entry.

The clinical clock is tight. The American Stroke Association says eligible ischemic stroke patients may receive alteplase or tenecteplase within 4.5 hours of symptom onset, while mechanical thrombectomy for eligible large-clot patients should be done as soon as possible and can apply up to 24 hours after symptoms begin. That timing makes referral design a board-level operating issue, rather than a narrow neurology protocol.

Why it matters for patients and payers

Eligibility for CoE treatment is clinical. DoH’s Centre of Excellence FAQ says patients are referred by a clinician when CoE treatment is necessary. It also states that non-UAE residents can be referred, with payment through self-pay or medical insurance coverage. Abu Dhabi providers should therefore verify Daman and Thiqa coverage rules at the point of transfer, and commercial insurance teams should confirm whether the planned CoE is inside the member’s network.

The price signal is less public than the clinical signal. DoH did not publish a patient tariff in the 9 October 2026 announcement. Finance teams should use DoH’s Shafafiya prices, payer fee schedules and procedure codes for a case-specific estimate. For Dubai and Northern Emirates patients, the same check should include DHA or MOHAP facility licensing status, insurer network access and whether an Abu Dhabi transfer needs prior approval after emergency stabilisation.

The next item to watch is whether STMC appears in DoH’s public CoE directory with updated referral instructions and whether payers revise network language for Al Ain stroke cases. UAE clinics that manage hypertension, atrial fibrillation, diabetes or post-stroke rehabilitation should also review nearby licensed cardiology and cardiovascular providers in the UAE Open Healthcare Directory before updating referral scripts for patients.